Viewing Study NCT03462251

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2026-05-05 @ 10:08 AM
Study NCT ID: NCT03462251
Status: COMPLETED
Last Update Posted: 2023-01-19
First Post: 2018-02-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line
Sponsor: iOMEDICO AG
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Hormone Receptor Positive Tumor View
None HER 2 Negative Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast Cancer View
None HR positive View
None HER2 negative View
None Mamma carcinoma View